Shares of Bio-Techne Corp. advanced 7.39% to $50.91 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,337.11 and Dow ...
StockStory.org on MSN
Bio-Techne (NASDAQ:TECH) reports sales below analyst estimates in Q1 CY2026 earnings
Life sciences company Bio-Techne (NASDAQ:TECH) in Q1 CY2026, with sales falling 1.5% year on year to $311.4 million. Its ...
The consensus price target hints at a 163.4% upside potential for Q32 Bio (QTTB). While empirical research shows that this ...
Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...
On February 17, 2026, Knoll Capital Management disclosed a purchase of 473,591 shares of Nuvation Bio (NYSE:NUVB), an estimated $2.93 million trade based on quarterly average pricing. Nuvation Bio is ...
PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (PASG) (“Passage Bio” or the “Company”) (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results